Rezan Koçak Ulucaköy et al. 2024. Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?. Archives of Rheumatology. 39, 3 (Sep. 2024), 368–374. DOI:https://doi.org/10.46497/ArchRheumatol.2024.10360.